Archives for October 14, 2009

← 2009

CPhI 2009 - Road to recovery?

By Nick Taylor

As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success.

ACRO wants trials for most biosimilars

By Gareth Macdonald

ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars